Proteomics International: Raises $6M for high-tech blood test

  • Proteomics International (PIQ) has received firm commitments to undertake a $6 million share placement
  • 12.5 million shares will issued to sophisticated and professional investors at 48 cents each
  • Additionally, the company will issue 2.2 million options to Euroz Hartleys Securities and Candour Advisory
  • These options will have an exercise price of 75 cents with expiry two years after issue
  • Proteomics will also use the funds to manufacture, market, and speed-up regulatory approvals for its PromarkerD test and strengthen its balance sheet
  • Proteomics is up 9 per cent on the market with shares trading for 60 cents each
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

US Launches Cybersecurity Sharing Channel for Crypto Firms

New initiative aims to enhance security in the cryptocurrency sector.Highlights: US government launches a new cybersecurity sharing channel...

PayPal Expands Payment Links to Canva Creators

Canva users can now easily monetize their designs with PayPal's new feature.Highlights: PayPal's payment links feature is now...

Perpetuals Strengthens AI with Quantum Resilience as a Service

The new offering promises enhanced stability and security for fintech operations.Highlights: Perpetuals launches unique Quantum Resilience as a...

Revolut Introduces AI Assistant for Money Management

New feature aims to enhance personal finance management for users.Highlights: Revolut launches an AI assistant for better money...